News & Updates

CV health tool effectively promotes discussions during routine follow-up in cancer survivors
CV health tool effectively promotes discussions during routine follow-up in cancer survivors
06 Jul 2023 byAudrey Abella

A novel electronic health record (EHR) clinical decision support tool, otherwise called the AH-HA* tool, was effective in promoting cardiovascular health (CVH) discussions among cancer survivors during routine follow-up. This was the primary result of a clinic-randomized, hybrid effectiveness-implementation trial presented at ASCO 2023.

CV health tool effectively promotes discussions during routine follow-up in cancer survivors
06 Jul 2023
Once-weekly icodec affords greater blood sugar reduction than once-daily degludec in T2D
Once-weekly icodec affords greater blood sugar reduction than once-daily degludec in T2D
03 Jul 2023

In the treatment of individuals with insulin-naïve type 2 diabetes (T2D), once-weekly icodec yields superior HbA1c reduction compared with once-daily degludec, according to the results of a phase IIIa trial.

Once-weekly icodec affords greater blood sugar reduction than once-daily degludec in T2D
03 Jul 2023
Type 1 diabetes carries increased risk of heart failure
Type 1 diabetes carries increased risk of heart failure
03 Jul 2023

Individuals with type 1 diabetes mellitus (T1DM) have a heightened risk of heart failure compared with those who have no diabetes, according to a study.

Type 1 diabetes carries increased risk of heart failure
03 Jul 2023